Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by stockman6767on Apr 25, 2019 7:28pm
151 Views
Post# 29672295

The clearest showing of how manifestly unfair the SALP desig

The clearest showing of how manifestly unfair the SALP desig

The clearest showing of how manifestly unfair the SALP designed restructure was to the original shareholders, and conversely ho very overly generous they were with what they gave themselves – many multiples of what they needed to protect their $100 million and the new money from both SALP and Consonance. So at 1.5 cents the market cap of the nearly 21 BILLION shares they now own is approximately $320,000,000. Overnight the have more than doubled their money just by virtue of the restructure. This is way more than they should have received to protect their investment. There was absolutely no reason to give them a penny more without a vote of the shareholders.

 

On the other hand the original investors where downsized from value from before the restructure say 30 to 60 cents (to be conservative I will use 30 cents). Unlike SALP, they LOST about 28.5/30  = 0.95 or 95% of their investment.

 

Bottom line the score is: SALP get a double, Investors get the shaft with a loss of 95%.

 

So even if you grant SALP the hardship application (which of course I do not) the terms they set up for the restructure were crazily unfair and totally lacked any rhyme or reason or justice or sense of fair play.

 

THIS MUST BE OVERTURNED OR THERE IS NO JUSTICE.

 

 


Bullboard Posts